IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. — Investor Relations & Filings
IMEIK Technology Development Co., Ltd. focuses on the research, development, and commercialization of biomedical materials, specifically targeting the aesthetic medicine sector. The company’s primary product line consists of injectable hyaluronic acid fillers and facial implants designed for soft tissue repair and augmentation. Utilizing proprietary cross-linking technologies, the firm produces high-purity formulations such as Hi-Tech and Hearty. Its portfolio also encompasses skin repair products and solutions for minimally invasive procedures. The organization prioritizes technological innovation and maintains a robust pipeline of Class III medical device registrations. By leveraging advanced biotechnology, the company provides clinical-grade materials to medical institutions and specialized clinics, emphasizing safety, efficacy, and biocompatibility in its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第三届监事会第六次会议决议公告 | 2023-10-17 | Chinese | |
| 上海荣正企业咨询服务（集团）股份有限公司关于爱美客技术发展股份有限公司2023年第一期限制性股票激励计划预留授予相关事项之独立财务顾问报告 | 2023-10-17 | Chinese | |
| 独立董事关于第三届董事会第八次会议相关事项的独立意见 | 2023-10-17 | Chinese | |
| 关于向2023年第一期限制性股票激励计划激励对象授予预留限制性股票的公告 | 2023-10-17 | Chinese | |
| 北京海润天睿律师事务所关于爱美客技术发展股份有限公司2023年第一期限制性股票激励计划授予价格调整、预留部分授予事项的法律意见 | 2023-10-17 | Chinese | |
| 第三届董事会第八次会议决议公告 | 2023-10-17 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 38854728 | 第三届监事会第六次会议决议公告 | 2023-10-17 | Chinese | ||
| 38854718 | 上海荣正企业咨询服务（集团）股份有限公司关于爱美客技术发展股份有限公司2023年第一期限制性股票激励计划预留授予相关事项之独立财务顾问报告 | 2023-10-17 | Chinese | ||
| 38854712 | 独立董事关于第三届董事会第八次会议相关事项的独立意见 | 2023-10-17 | Chinese | ||
| 38854703 | 关于向2023年第一期限制性股票激励计划激励对象授予预留限制性股票的公告 | 2023-10-17 | Chinese | ||
| 38854691 | 北京海润天睿律师事务所关于爱美客技术发展股份有限公司2023年第一期限制性股票激励计划授予价格调整、预留部分授予事项的法律意见 | 2023-10-17 | Chinese | ||
| 38854671 | 第三届董事会第八次会议决议公告 | 2023-10-17 | Chinese | ||
| 38854659 | 2023半年度分红派息实施公告 | 2023-10-15 | Chinese | ||
| 38854651 | 首次公开发行前已发行股份上市流通提示性公告 | 2023-10-08 | Chinese | ||
| 38854639 | 关于公司控股股东、董事、员工持股平台自愿承诺不减持公司股份的公告 | 2023-10-08 | Chinese | ||
| 38854630 | 中信证券股份有限公司关于爱美客技术发展股份有限公司首次公开发行前已发行股份上市流通的核查意见 | 2023-10-08 | Chinese | ||
| 38854615 | 关于举行2023年半年度网上业绩说明会的公告 | 2023-09-19 | Chinese | ||
| 38854604 | 2023年第一次临时股东大会决议公告 | 2023-09-13 | Chinese | ||
| 38854594 | 北京海润天睿律师事务所关于爱美客技术发展股份有限公司2023年第一次临时股东大会的法律意见书 | 2023-09-13 | Chinese | ||
| 38854585 | 中信证券股份有限公司关于爱美客技术发展股份有限公司2023年半年度跟踪报告 | 2023-09-04 | Chinese | ||
| 38854570 | 关于回购公司股份进展的公告 | 2023-09-01 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55863/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55863 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55863 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55863 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55863}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. (id: 55863)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.